IL-2 and IL-6 secretion in dementia: correlation with type and severity of disease

J Neurol Sci. 1995 Jun;130(2):161-4. doi: 10.1016/0022-510x(95)00016-u.

Abstract

The production of interleukin-2 (IL-2) and interleukin-6 (IL-6) by peripheral blood mononuclear cells (MNC) was assessed in patients with Alzheimer's disease (AD) who were subdivided into two groups--mild and moderately-severe--according to the severity of the disease, probable vascular dementia (VaD) patients and elderly control subjects. No differences in IL-2 secretion were found between mild AD patients and controls. However, there was a significant increase in IL-2 production both in the moderately-severe AD group and in the VaD group. IL-6 levels in AD patients of both groups were similar and significantly higher than those of VaD and controls. Our results suggest that increased levels of IL-2-production correlate with severity of the dementia, whereas increased levels of IL-6 production seem to be related to AD and thus may play a role in AD pathogenesis.

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / psychology
  • Dementia / metabolism*
  • Dementia / psychology
  • Dementia, Multi-Infarct / metabolism
  • Dementia, Multi-Infarct / psychology
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Interleukin-2 / metabolism*
  • Interleukin-6 / metabolism*
  • Male
  • Psychiatric Status Rating Scales

Substances

  • Interleukin-2
  • Interleukin-6